Send PM
Followers 22
Posts 1712
Boards Moderated 0
Alias Born 07/09/2005

Re: None

Monday, 11/29/2021 2:09:11 PM

Monday, November 29, 2021 2:09:11 PM

Post# of 282
Affimed: A small-cap biotech with room to run
Bucking the downward trend in biopharma in 2021, Affimed, a small-cap cancer immunotherapy company, has seen its shares actually rise by a healthy 19.8% this year. This tiny immunotherapy company has been able to swim against the current this year due to some truly eye-catching clinical trial data.

Last week, Affimed reported that its lead product candidate AFM13, when combined with a dose of natural killer cells, produced a 100% objective response rate in heavily pre-treated patients with recurrent or refractory CD30-positive lymphomas. AFM13 is thus on track to become the go-to therapy for later-line CD30-positive lymphomas; an indication that ought to be worth around $500 million to $600 million in sales per year.

To put these extremely preliminary revenue figures into context, Affimed currently sports a market cap of just $834 million. That's the key reason why Wall Street thinks this stock could more than double in value over the next 12 months.

Despite its relatively strong year, Affimed's novel anti-cancer platform still comes off as grossly undervalued at these levels. The company could eventually generate billions in sales and it stands out as a top buyout target right now.
https://www.fool.com/investing/2021/11/28/3-best-biopharma-stocks-to-buy-during-this-industr/

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Recent AFMD News

FEATURED Ludwig's genomic-based mRNA Inflammatory Index - a Ground-Breaking Technology Sep 28, 2022 1:34 PM

Headwater Gold Commences Multi-Rig Drill Program at the Spring Peak Project, Nevada to Follow Up Epithermal Vein Discoveries HWAUF Sep 28, 2022 10:13 AM

Valiant Eagle Inc. (OTC: PSRU) Significantly Increases Its Equity Stake in Sumer Technologies, Inc., as the Ride-Sharing Company Readies Its Much Anticipated Innovative Zumr App For Q1 2023 U.S. Launch PSRU Sep 28, 2022 9:30 AM

Good Gaming Inc. Announces Official Launch Date For Their New Minecraft OP Prison Game Featuring MicroBuddiesTM GMER Sep 28, 2022 9:15 AM

Trend Innovations Holding Inc. Completes the Second Version of the AI Consultant Chatbot on the Company's Website TREN Sep 28, 2022 9:00 AM

GBT will be attending the Interactive MoneyShow Virtual Expo, on Sep 27-29, Presenting its Technologies, Innovations and Future Visions GTCH Sep 28, 2022 7:30 AM

Branded Legacy, Inc. Reduces Authorized Shares By 300 Million BLEG Sep 27, 2022 11:53 AM

Acquisition Completed: Endexx (EDXC)'s HYLA Secures 200k+ Unit Order; 4,500 Puffs per Unit AVXL Sep 27, 2022 9:33 AM

Integrated Ventures is set to report 254% annual revenue growth, fueled by expansion of crypto mining operations INTV Sep 27, 2022 9:22 AM

SNAKES & LATTES INC. (OTC: FUNN) is Pleased to Report an Almost 200% Increase in Year Over Year FY22 Revenue at $6,064,896, up From $2,027,988 for FY21, With Gross Profits up From $1,369,514 to $4,223,022 FUNN Sep 27, 2022 8:14 AM

ILUS Confirms Its First Investment Project in Serbia ILUS Sep 26, 2022 12:23 PM

Thunder Energies Engages Geological Experts For Gold and Minerals Assessment TNRG Sep 26, 2022 9:56 AM

CERRADO GOLD CONFIRMS OVER 250 METRES OF MINERALIZED STRIKE AT GOGO´ DA ONC¸A EXPLORATION TARGET AT ITS MONTE DO CARMO PROJECT, BRAZIL CRDOF Sep 26, 2022 9:45 AM

HealthLynked Announces Upgrades to its MedOfficeDirect Ecommerce Site for Discount Medical Supplies HLYK Sep 23, 2022 8:00 AM

ResGreeen Uses Open-Source Robot Operating System (ROS) to Enhance Integration and Simulation for LilBuddy AMR RGGI Sep 22, 2022 1:58 PM